1.
Mol Psychiatry
; 10(3): 232-5, 2005 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15599378
2.
Am J Psychiatry
; 158(6): 970, 2001 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-11384923
Assuntos
Metadona/efeitos adversos , Transtornos Relacionados ao Uso de Opioides/reabilitação , Psicoses Induzidas por Substâncias/etiologia , Síndrome de Abstinência a Substâncias/etiologia , Alprazolam/efeitos adversos , Alprazolam/uso terapêutico , Benzodiazepinas/uso terapêutico , Esquema de Medicação , Feminino , Humanos , Hidrocodona/uso terapêutico , Metadona/uso terapêutico , Pessoa de Meia-Idade , Fatores de Tempo
3.
Indian J Psychiatry
; 37(1): 5-8, 1995 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21743706
RESUMO
Forty four patients attending the affective disorder clink at J1PMER Hospital who were on prophylactic lithium for bipolar affective disorder were studied, Intra-individual comparison for severity of illness was made between periods of similar duration with and without lithium prophylaxis. It was found that during lithium prophylaxis patients did significantly better on the following parameters: number of episodes of illness, duration of episodes, hospital admission, neuroleptic dosages and duration of antidepressant treatment. Of the 44 patients included in the study, 45% were good responders, 39% were partial responders and 16% were poor responders. Late age of onset was found to be a significant predictor of good response to lithium.